Go to article
Posted by CoV Report on December 26, 2021 10:29 amTags: Categories: Global Stories
U.S. regulators authorized Pfizer’s pill, Paxlovid, and Merck’s molnupiravir this week.
Your email address will not be published. Required fields are marked *
Comment *
Name *
Email *
Website
Save my name, email, and website in this browser for the next time I comment.
< The Coronavirus Report home
Everything you need to know to stay updated on the Coronavirus
Leave a Reply